We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+8.38%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$3.84B
AUM Growth
-$2.1B
Cap. Flow
-$2.45B
Cap. Flow %
-63.69%
Top 10 Hldgs %
22.61%
Holding
6,382
New
824
Increased
1,880
Reduced
2,765
Closed
701

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$120M
2
MSFT icon
Microsoft
MSFT
+$115M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$72.4M
4
AMZN icon
Amazon
AMZN
+$69.8M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$51.2M

Sector Composition

Rank Sector Weight
1 Technology 19.05%
2 Consumer Discretionary 11.67%
3 Healthcare 9.59%
4 Financials 9.24%
5 Communication Services 7.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPYM
4401
State Street SPDR Portfolio S&P 500 ETF
SPYM
$169B
$10K ﹤0.01%
200
-142,351
-100% -$6.99M
TLYS icon
4402
Tilly's
TLYS
$130M
$10K ﹤0.01%
619
-6,248
-91% -$84.2K
TRVI icon
4403
Trevi Therapeutics
TRVI
$2.54B
$10K ﹤0.01%
4,187
+2,950
+238% +$6.64K
UBCP icon
4404
United Bancorp
UBCP
$93M
$10K ﹤0.01%
703
+337
+92% +$5.04K
VIVO
4405
VivoPower PLC
VIVO
$121M
$10K ﹤0.01%
143
-81
-36% -$6.25K
WYY icon
4406
WidePoint Corp
WYY
$111M
$10K ﹤0.01%
1,261
-972
-44% -$7.65K
DWTX
4407
Dogwood Therapeutics
DWTX
$61.5M
$10K ﹤0.01%
61
+33
+118% +$4.68K
SPRB
4408
Spruce Biosciences
SPRB
$127M
$10K ﹤0.01%
12
+3
+33% +$3.2K
AKTS
4409
DELISTED
Akoustis Technologies Inc
AKTS
$10K ﹤0.01%
927
-492
-35% -$5.2K
PUCK
4410
DELISTED
Goal Acquisitions Corp. Common Stock
PUCK
$10K ﹤0.01%
+1,004
New +$9.71K
GTH
4411
DELISTED
Genetron Holdings Limited ADS
GTH
$10K ﹤0.01%
+160
New +$9.88K
BTWN
4412
DELISTED
Bridgetown Holdings Limited Class A Ordinary Shares
BTWN
$10K ﹤0.01%
+943
New +$9.79K
HMPT
4413
DELISTED
Home Point Capital, Inc Common Stock
HMPT
$10K ﹤0.01%
1,740
+288
+20% +$2.21K
ATTO
4414
DELISTED
Atento S.A.
ATTO
$10K ﹤0.01%
+381
New +$8.31K
ARVL
4415
DELISTED
Arrival Ordinary Shares
ARVL
$10K ﹤0.01%
13
-57
-81% -$50.5K
HPX.U
4416
DELISTED
HPX Corp. Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant
HPX.U
$10K ﹤0.01%
946
ASAQ.U
4417
DELISTED
Atlantic Avenue Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one warrant
ASAQ.U
$10K ﹤0.01%
1,000
-9
-0.9% -$91
NSEC
4418
DELISTED
National Security Group Inc
NSEC
$10K ﹤0.01%
999
-172
-15% -$1.88K
DCUE
4419
DELISTED
Dominion Energy, Inc. 2019 Series A Corporate Units
DCUE
$10K ﹤0.01%
100
-101
-50% -$10.2K
HBP
4420
DELISTED
Huttig Building Products, Inc.
HBP
$10K ﹤0.01%
+1,743
New +$9.22K
DCRN
4421
DELISTED
Decarbonization Plus Acquisition Corporation II Class A Common stock
DCRN
$10K ﹤0.01%
+1,015
New +$9.96K
HZAC.U
4422
DELISTED
Horizon Acquisition Corporation Units, each consisting of one Class A ordinary share and one-third o
HZAC.U
$10K ﹤0.01%
974
-395
-29% -$4.13K
MAAC
4423
DELISTED
Montes Archimedes Acquisition Corp. Class A Common Stock
MAAC
$10K ﹤0.01%
+989
New +$9.76K
IFFT
4424
DELISTED
International Flavors & Fragrances Inc. 6.00% Tangible Equity Units
IFFT
$10K ﹤0.01%
200
+172
+614% +$8.61K
PFPT
4425
DELISTED
Proofpoint, Inc.
PFPT
$10K ﹤0.01%
60
-4,091
-99% -$664K

Similar funds

Tower Research Capital (TRC)'s Q2 2021 Portfolio in Review

As of Q2 2021, Tower Research Capital (TRC) held 6,382 positions worth $3.84B, down 35% from $5.94B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Tower Research Capital (TRC) withdrew a net $2.45B in Q2 2021, closing 701 positions and reducing 2,765 holdings. Its most notable exit was iShares Russell 1000 Growth ETF, an estimated $15.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in Invesco NASDAQ Biotechnology ETF worth $8.44M.

  • Tower Research Capital (TRC)'s largest Q2 2021 buy was Invesco NASDAQ Biotechnology ETF: 325,629 shares worth $8.44M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $175M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2021 reduction was Apple, cutting an estimated $120M.
  • Tower Research Capital (TRC) fully exited iShares Russell 1000 Growth ETF in Q2 2021, selling an estimated $15.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 23% of its $3.84B portfolio in Q2 2021.
  • Tower Research Capital (TRC) opened 824 new positions and closed 701 in Q2 2021.
  • Tower Research Capital (TRC)'s portfolio value fell 35% quarter-over-quarter to $3.84B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2021, filed 16 Aug 2021.